Skip to main content
. 2015 Apr-Jun;4(2):88–90. doi: 10.4103/2278-330X.155693

Figure 2.

Figure 2

p53 immunoreactivity (%), apoptotic index and DNA aneuploidy in carcinoma prostate cases in relation with hormone response, clinical stage, and Gleason score